Masha Paule Nathalie Strømme
Director/Board Member presso EXACT THERAPEUTICS
Patrimonio netto: 1 M $ in data 31/03/2024
Posizioni attive di Masha Paule Nathalie Strømme
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| EXACT THERAPEUTICS | Director/Board Member | 08/06/2022 | - |
| Chairman | 22/06/2018 | 08/06/2022 | |
Fortuna Fix, Inc.
 Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | Director/Board Member | - | - |
| Founder | - | - | |
| Corporate Officer/Principal | - | - | |
Hemispherian AS
 Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | Director/Board Member | - | - |
| PAACS Invest AS | Chairman | 01/09/2015 | - |
Storia della carriera di Masha Paule Nathalie Strømme
Precedenti posizioni note di Masha Paule Nathalie Strømme
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NAVAMEDIC ASA | Director/Board Member | 18/06/2010 | 30/10/2015 |
| AQUA BIO TECHNOLOGY ASA | Director/Board Member | 05/07/2011 | 14/06/2012 |
Pharmasum Therapeutics AS
 Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Director/Board Member | - | - |
| ARCTICZYMES TECHNOLOGIES ASA | Director/Board Member | - | - |
Formazione di Masha Paule Nathalie Strømme
| University of Oxford | Doctorate Degree |
Statistiche
Distribuzione geografica
| Norvegia | 8 |
| Regno Unito | 2 |
| Canada | 2 |
Posizioni
| Director/Board Member | 7 |
| Chairman | 2 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 5 |
| Process Industries | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| AQUA BIO TECHNOLOGY ASA | Process Industries |
| ARCTICZYMES TECHNOLOGIES ASA | Health Technology |
| NAVAMEDIC ASA | Distribution Services |
| EXACT THERAPEUTICS | Health Technology |
| Aziende private | 4 |
|---|---|
| PAACS Invest AS | |
Fortuna Fix, Inc.
Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | Health Technology |
Pharmasum Therapeutics AS
Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Health Technology |
Hemispherian AS
Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | Commercial Services |
